Neil Sengupta to Crohn Disease
This is a "connection" page, showing publications Neil Sengupta has written about Crohn Disease.
Connection Strength
0.225
-
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease. Clin Gastroenterol Hepatol. 2022 07; 20(7):1579-1587.e2.
Score: 0.125
-
Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Aliment Pharmacol Ther. 2018 Apr; 47(7):913-921.
Score: 0.100